Lebanon vs Lower-middle income (World Bank): HIV-positive TB patients on ART (antiretroviral therapy)
Lebanon
100.0%
in 2024
Lower-middle income (World Bank)
95.0%
in 2024
Lebanon rank
1st
Lower-middle income (World Bank) rank
3rd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Lebanon
- Lower-middle income (World Bank)
How they compare
Lebanon currently reports 100.0% against 95.0% in Lower-middle income (World Bank), a difference of 5.0%.
That makes Lebanon's figure about 1.1 times Lower-middle income (World Bank)'s.
The two have swapped places 6 times across 17 shared years of data; in 2007 it was Lebanon ahead.
Lebanon ranks 1st and Lower-middle income (World Bank) ranks 3rd of 144 countries.
Across the 3 decades both report, Lebanon averaged higher in 2 and Lower-middle income (World Bank) in 1.
Head to head by decade
| Decade | Lebanon | Lower-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 32.7% | 67.3% | Lebanon |
| 2010s | 88.5% | 75.8% | 12.7% | Lebanon |
| 2020s | 91.8% | 93.8% | 2.0% | Lower-middle income (World Bank) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Lebanon or Lower-middle income (World Bank)?
- Lebanon, at 100.0% against 95.0% in Lower-middle income (World Bank) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Lebanon and Lower-middle income (World Bank)?
- 5.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Lower-middle income (World Bank)?
- 17 years are reported by both, from 2007 to 2024.
- How do Lebanon and Lower-middle income (World Bank) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Lebanon ranks 1st and Lower-middle income (World Bank) ranks 3rd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.